TG Therapeutics TGTX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from TG Therapeutics’s reported figures.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's invested capital?
- TG Therapeutics (TGTX) reported invested capital of $894.48M in Q1 2026.
- How has TG Therapeutics's invested capital changed year-over-year?
- TG Therapeutics's invested capital increased by 149.3% year-over-year, from $358.86M to $894.48M.
- What is the long-term trend for TG Therapeutics's invested capital?
- Over 5 years (2020 to 2025), TG Therapeutics's invested capital has grown at a 153.3% compound annual growth rate (CAGR), from $7.89M to $822.58M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).